Key result
Higher baseline atherogenic indices were associated with a significantly faster rate of increase in depressive symptom scores over time among women (γ +0.20, p=0.013 for LDL-C:HDL-C), but not men.
Why the study?
Do serum total cholesterol and atherogenic indices predict longitudinal changes in depressive symptoms in urban adults?
Cohort (n=1,925)
No
Do serum total cholesterol and atherogenic indices predict longitudinal changes in depressive symptoms in urban adults?
Effect estimate: γ +0.20 (SE 0.08) for LDL-C:HDL-C × time in women
p-value: p=0.013
Higher atherogenic indices are associated with a faster increase in depressive symptoms over time in women, suggesting a sex-specific link between lipid profiles and mental health.
Atherogenic indices may flag faster depressive worsening in women; hypothesis-generating and should not yet change practice.
Serum cholesterol, both total and lipoprotein fractions, has been associated with mid- and late-life depression. Using longitudinal data on a large and ethnically diverse sample of urban adults, the associations of serum lipid profile measured by high or low total cholesterol (TC; >200 mg dl(-1); <160 mg dl(-1)) and by atherogenic indices, namely high total cholesterol and low-density lipoprotein cholesterol relative to high-density lipoprotein cholesterol, with change in total and domain-specific depressive symptoms over time were examined. Findings were compared by sex. (Hypothesis 1) In addition, baseline depressive symptoms as predictors for longitudinal change in lipid profile trajectory were tested. (Hypothesis 2) Mixed-effects regression analyses stratified by sex was used. Sample sizes of participants (n) and repeated observations (n') were: Hypothesis 1 (Men: n=826 ; n'=1319; Women: n=1099 ; n'=1817); Hypothesis 2 (Men: n=738; n'=1230; Women: n=964; n'=1678). As hypothesized, a higher level of atherogenic indices was linked to faster increase in depressive symptom scores, particularly depressed affect and interpersonal problems, though this relationship was found only among women. Among men a U-shaped relationship between baseline TC and longitudinal increase in somatic complaints and a direct link between low TC and longitudinal putative improvement in positive affect was found. On excluding statin users among women, low TC was associated with slower increase in depressed affect over time, whereas high TC was associated with faster increase in interpersonal problems. In summary, atherogenic indices were directly linked to faster increase in depressive symptoms among women only. More studies are needed to explain these sex-specific associations.
No takes yet. Share an insight, caveat, or question.
Beydoun et al. (2015) conducted a cohort in Depressive symptoms (n=1,925). Atherogenic indices (TC:HDL-C and LDL-C:HDL-C) and Total Cholesterol vs. Lower atherogenic indices / Medium Total Cholesterol was evaluated on Change in total depressive symptoms (CES-D score) over time (γ +0.20 (SE 0.08) for LDL-C:HDL-C × time in women, p=0.013). Higher baseline atherogenic indices were associated with a significantly faster rate of increase in depressive symptom scores over time among women (γ +0.20, p=0.013 for LDL-C:HDL-C), but not men.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: